Susceptibility-based visualization for traumatic brain injury.
STAGE derives QSM and susceptibility-weighted outputs from one acquisition — additional information for teams reviewing microbleeds and vascular injury, being evaluated with clinical partners.
Microbleeds and shearing injury are easy to miss.
Traumatic microbleeds and diffuse axonal shearing injury are often subtle or entirely missed on conventional or lower-resolution scans, particularly when field strength or scanner protocol varies between the baseline exam and follow-up.
Two complementary views of susceptibility
Where conventional series can render small hemorrhagic foci as faint or ambiguous, STAGE's susceptibility-based outputs give reviewing teams additional, co-registered information from the same acquisition — reconstructed once and exported as a standard DICOM series.
One acquisition. The scanners you already have.
STAGE runs as a single multi-echo sequence, vendor-agnostic across 1.5T and 3T, with outputs landing in PACS as a standard DICOM series alongside the rest of the exam — no new hardware to standardize a mixed fleet.